IONS:NASDAQ
Ionis Pharmaceuticals Inc
$56.02
arrow_downward
-1.22%(-0.69) 1D
$56.00
arrow_downward
-0.04% (-0.020)bedtimeAfter hours
Closed: Sep 9, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IONS...
Open
$56.38
High
$56.96
Low
$55.70
Mkt. cap
9.31B
Avg. vol.
2.63M
Volume
0.00
52-wk high
$86.74
52-wk low
$50.01
EPS
-$3.47
Beta
0.42
Shares outstanding
166.18M
No. of employees
1K
Open
$56.38
High
$56.96
Low
$55.70
Mkt. cap
9.31B
Avg. vol.
2.63M
Volume
0.00
52-wk high
$86.74
52-wk low
$50.01
EPS
-$3.47
Beta
0.42
Shares outstanding
166.18M
No. of employees
1K
News stories
From web sources and news partners
Yahoo Finance
·
9 hours ago
Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making.
Zacks
·
11 hours ago
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall
News Corp
·
1 day ago
Novartis Stock Tanks Following Third Major Pipeline Setback
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websiteionis.com